title: Effect of limited modification of amino groups on the reactivity of human factor Xa.
abstract: The basis of the specificity of human coagulation factor Xa has been probed with a reagent that reacts with nucleophiles, N-succinimidylpropionate. At pH 8.0 and 0.25 mM N-succinimidylpropionate, 0.4 microM factor Xa lost approx. 90% of its activity toward prothrombin in 4 min. The decay was first-order, k = 0.64 min-1, which increased to 0.98 min-1 in 1 mM Ca2+, and the dependence of k upon pH was consistent with primary amines being the target. The rate of modification was unaffected by the presence of a tetrapeptide substrate during modification; likewise, activity toward a tripeptide p-nitroanilide was unaltered during exposure of factor Xa to N-succinimidylpropionate with or without Ca2+. In addition, inhibition by antithrombin III was retained with a somewhat enhanced rate after modification; however, the acceleration of this by heparin was significantly less. Kinetic determination of the number of residues modified gave a reaction order of 2.0, while reaction with N-succinimidyl[3H]propionate yielded labeled factor Xa containing 1.0 mol N-succinimidylpropionate/mol factor Xa and 50% normal clotting activity, or 2.0 mol N-succinimidylpropionate/mol and 1% activity, respectively. Thus, one nucleophilic group is required for the reaction of factor Xa with prothrombin but not for the hydrolysis of peptides or recognition of antithrombin III. The decay of clotting activity of the factor X zymogen in N-succinimidylpropionate was much slower though still Ca2+-dependent. Conversely, the reaction of a related compound--N-succinimidyl(4-hydroxyphenyl)propionate or Bolton-Hunter reagent--with factor Xa broadly resembled that of N-succinimidylpropionate but the decay curves indicated more complex kinetics. Therefore, the target groups vary in their accessibility to modification according to the structural characteristics of both the protein and the reagent.
mesh_terms: D000990:Antithrombin III / Q000302:isolation & purification / Q000378:metabolism; D002118:Calcium / Q000494:pharmacology; D005170:Factor X / Q000302:isolation & purification / Q000378:metabolism*; D015951:Factor Xa; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D011422:Propionates / Q000494:pharmacology*; D011516:Prothrombin / Q000378:metabolism*
chemical_list: D011422:Propionates; C021749:N-succinimidyl propionate; D000990:Antithrombin III; D011516:Prothrombin; D005170:Factor X; D015951:Factor Xa; D002118:Calcium